![Petros Grivas about Perioperative treatment in MIBC at Libyan Association of Urology/Scientific Day](https://oncodaily.com/pub/uploads/2024/09/Screenshot-2024-09-05-000743.png)
Petros Grivas about Perioperative treatment in MIBC at Libyan Association of Urology/Scientific Day
Petros Grivas shared a post by Refaat Abusamra, Chairman of Uro-oncology Section of Libyan Urological Association on X, adding:
“Thanks for the invite Refaat Abusamra, Société Internationale d’Urologie (SIU). It was my pleasure to give virtual talk in Libya.”
Quoting Refaat Abusamra:
“Dear Prof. Dr. Petros Grivas & a very important presentation at our meeting on MIBC 30 Aug.24 about Perioperative treatment in MIBC thank you very much it was great & thanks are due SIU.”
Source: Petros Grivas/X and Refaat Abusamra/X
Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance. He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023